Organic growth of 7.1% for the Bastide Group in Q1 2026-2027

The Bastide Group, a major player in home healthcare in Europe, recorded organic growth of 7.1% in the first quarter of fiscal year 2026-2027, with revenue of €124.3 million. Home healthcare services, including the Respiratory and Diabetes segments, showed organic growth of 7.8%. Similarly, the home care business grew by 6.2%, driven by the performance of its stores and community facilities.

The Respiratory business stood out with 10.6% growth, despite a price decrease in France, thanks to market expansion and strategic acquisitions. Internationally, business increased by 20%, driven by strong performance in Italy and the United Kingdom.

The Group plans a dividend of €0.41 per share for the 2025-2026 financial year, and aims for a turnover of at least €500 million for 2026-2027, while maintaining its operating margin.